CENTRYMED
Centrymed focuses on the field of tumor treatment, and its self-developed dual-antibody platform. The company's independent intellectual property rights have solved the problems of drug drugability and toxic and side effects of antibody drugs.
CENTRYMED
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.centrymed.com
Status:
Active
Contact:
86-0571-87314597
Total Funding:
0
Technology used in webpage:
Euro Apache 2.4 Japanese Yen CentOS Amap
Investors List
Betta Pharmaceuticals
Betta Pharmaceuticals investment in Series A - Centrymed
Yxassets.com
Yxassets.com investment in Series A - Centrymed
Anji Maisheng
Anji Maisheng investment in Series A - Centrymed
Chenghe Venture Capital
Chenghe Venture Capital investment in Series A - Centrymed
Binjiang District Government Fund Hang Gao Investment
Binjiang District Government Fund Hang Gao Investment investment in Series A - Centrymed
Taikun Capital
Taikun Capital investment in Series A - Centrymed
Guangzhou Yue Min Investment
Guangzhou Yue Min Investment investment in Series A - Centrymed
HongXin Venture Capital
HongXin Venture Capital investment in Series A - Centrymed
Official Site Inspections
http://www.centrymed.com
- Host name: 155.102.130.201
- IP address: 155.102.130.201
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
